---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-013968"
form_type: "8-K"
ticker: "ZVSA"
cik: "0001859007"
company_name: "ZyVersa Therapeutics, Inc."
filed_at: "2025-09-18T23:59:59+00:00"
generated_at: "2026-05-17T06:17:11.042670+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 1.0
calibrated_materiality_score: 1.0
confidence: "high"
source: SEC EDGAR
---

# Nasdaq to delist ZyVersa Therapeutics common stock effective ~Sep 28, 2025

## Summary
- Nasdaq notified ZyVersa on Sept 14, 2025, of delisting; Form 25 to be filed on or about Sept 18, 2025.
- Stock was suspended from Nasdaq on July 17, 2025; trading on OTCQB since July 28, 2025 under symbol ZVSA.
- Delisting effective ten days after Form 25 filing; company cites failure to meet minimum bid price rule.
- Company's common stock will continue trading on OTCQB without disruption.

## SEC filing metadata
- accession: 0001493152-25-013968
- form_type: 8-K
- ticker: ZVSA
- cik: 0001859007
- company_name: ZyVersa Therapeutics, Inc.
- filed_at: 2025-09-18T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 1.0
- calibrated_materiality_score: 1.0
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1859007/000149315225013968/0001493152-25-013968-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1859007/000149315225013968/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-013968
- JSON: https://secwatch.observer/filing/0001493152-25-013968.json
- Plain text: https://secwatch.observer/filing/0001493152-25-013968.txt

## Key facts
- Listing & Compliance Notices
  ZyVersa Therapeutics, Inc. received a nasdaq delisting notice notice regarding minimum bid price (rules 5550(a)(2)).
  - Exchange: nasdaq
  - Notice: delisting notice
  - Deficiency: minimum bid price
  - Rules: 5550(a)(2)
  source text: dicating that the Panel had determined to delist the Company’s securities from Nasdaq and that trading in the Company’s securities would be suspended at the open of trading on July 17, 2025, due to the Company’s failure to regain compliance with the minimum bid price requirements under Listing Rule 5550(a)(2) . CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS This Current Report on Form 8-K (“Form 8-K”) contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this Form 8-K that do not relate to matters of hi
  evidence_url: https://www.sec.gov/Archives/edgar/data/1859007/000149315225013968/0001493152-25-013968-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.